Gamma-hydroxybutyric acid.
Snead
O Carter
OC
Department of Pediatrics, University of Toronto, and the Division of Neurology and the Brain and Behavior Research Program, Hospital for Sick Children, Toronto, ON, Canada.
Gibson
K Michael
KM
D015107:4-Butyrolactone / Q000378:metabolism; D000818:Animals; D002072:Butylene Glycols / Q000378:metabolism; D006801:Humans; D006885:Hydroxybutyrates / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism; D018079:Receptors, GABA / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders
C039403:4-hydroxybutyric acid receptor; D002072:Butylene Glycols; D006885:Hydroxybutyrates; D011956:Receptors, Cell Surface; D011954:Receptors, Dopamine; D018079:Receptors, GABA; C111420:4-hydroxybutyric acid; C039681:1,4-butanediol; D015107:4-Butyrolactone